The use of Alu I to destroy DNA contamination in reverse transcription polymerase chain reaction and its advantages

Analytical Biochemistry

Volumn 366, Issue 1, 2007, Pages 99-101

  Wang, Tong Hong ^a   Tsai, Yi Ching ^b   Au, Lo Chun ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CHEMISTRY;

REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION;

POLYMERASE CHAIN REACTION;

ALU 1 ENZYME; DEOXYRIBONUCLEASE I; GENOMIC DNA; MAGNESIUM SULFATE; MESSENGER RNA; MSE 1 ENZYME; MSP 1 ENZYME; PLASMID DNA; RESTRICTION ENDONUCLEASE; RNA; TAQ POLYMERASE; UNCLASSIFIED DRUG;

AMPLICON; ARTICLE; CONTROLLED STUDY; DEGRADATION KINETICS; DNA DAMAGE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 34248561756     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.04.003     Document Type: Article

References (11)

1. Li J., Lee B., and Lee A.S. Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53. J. Biol. Chem. 281 (2006) 7260-7270
2. Kim H., You S., Kim I.J., Foster L.K., Farris J., Ambady S., Ponce de Leon F.A., and Foster D.N. Alterations in p53 and E2F-1 function common to immortalized chicken embryo fibroblasts. Oncogene 20 (2001) 2671-2682
3. Juan C.C., Au L.C., Fang V.S., Kang S.F., Ko Y.H., Kuo S.F., Hsu Y.P., Kwok C.F., and Ho L.T. Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids. Biochem. Biophys. Res. Commun. 289 (2001) 1328-1333
4. Bourdon J.C., Fernandes K., Murray-Zmijewski F., Liu G., Diot A., Xirodimas D.P., Saville M.K., and Lane D.P. p53 isoforms can regulate p53 transcriptional activity. Genes Dev. 19 (2005) 2122-2137
5. Ohtani S., Kagawa S., Tango Y., Umeoka T., Tokunaga N., Tsunemitsu Y., Roth J.A., Taya Y., Tanaka N., and Fujiwara T. Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo. Mol. Cancer Ther. 3 (2004) 93-100
6. Wen S.F., Xie L., McDonald M., DiGiacomo R., Chang A., Gurnani M., Shi B., Liu S., Indelicato S.R., Hutchins B., and Nielsen L.L. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models. Cancer Gene Ther. 7 (2000) 1469-1480
7. Hughes T.R., Hiley S.L., Saltzman A.L., Babak T., and Blencowe B.J. Microarray analysis of RNA processing and modification. Methods Enzymol. 410 (2006) 300-316
8. Staib F., Robles A.I., Varticovski L., Wang X.W., Zeeberg B.R., Sirotin M., Zhurkin V.B., Hofseth L.J., Hussain S.P., Weinstein J.N., Galle P.R., and Harris C.C. The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress. Cancer Res. 65 (2005) 10255-10264
9. Lin A.W., Usera M.A., Barrett T.J., and Goldsby R.A. Application of random amplified polymorphic DNA analysis to differentiate strains of Salmonella enteritidis. J. Clin. Microbiol. 34 (1996) 870-876
10. Newton C.R., and Grahan A. PCR (1994), BIOS Scientific Publishers, Oxford, UK
11. Molloy P.L., and Symons R.H. Cleavage of DNA.RNA hybrids by type II restriction enzymes. Nucleic Acids Res. 8 (1980) 2939-2946